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Beclin1Among the large number of variants belonging to the pancreatic-type secretory ribonuclease (RNase) superfam-
ily, bovine pancreatic ribonuclease (RNase A) is the proto-type and bovine seminal RNase (BS-RNase) represents
the unique natively dimeric member. In the present manuscript, we evaluate the anti-tumoral property of these
RNases in pancreatic adenocarcinoma cell lines and in nontumorigenic cells as normal control. We demonstrate
that BS-RNase stimulates a strong anti-proliferative and pro-apoptotic effect in cancer cells, while RNase A is
largely ineffective. Notably, we reveal for the ﬁrst time that BS-RNase triggers Beclin1-mediated autophagic can-
cer cell death, providing evidences that high proliferation rate of cancer cells may render themmore susceptible
to autophagy byBS-RNase treatment. Notably, to improve the autophagic response of cancer cells to BS-RNasewe
used two different strategies: themore basic (as compared toWT enzyme) G38Kmutant of BS-RNase, known to
interact more strongly than wt with the acidic membrane of cancer cells, or BS-RNase oligomerization
(tetramerization or formation of larger oligomers). Both mutant BS-RNase and BS-RNase oligomers potentiated
autophagic cell death as compared to WT native dimer of BS-RNase, while the various RNase A oligomers
remained completely ineffective. Altogether, our results shed more light on the mechanisms lying at the basis
of BS-RNase antiproliferative effect in cancer cells, and support its potential use to develop new anti-cancer
strategies.
© 2014 Elsevier B.V. All rights reserved.1. Introduction
Pancreatic adenocarcinoma is one of the most aggressive and devas-
tating human malignancies and the fourth leading cause of worldwide
cancer-related deaths. Standard treatments for advanced disease include
monotherapy with gemcitabine (2′,2′-diﬂuoro-2′-deoxycytidine), which
has, however, a response rate of less than 20% [1]. Therefore, during the
last few years, the identiﬁcation of valuable targets [2,4] and novel
efﬁcient therapeutic strategies against pancreatic adenocarcinoma has
been extensively investigated [5,7]. Among the biological events associat-
ed with the response of cancer cells to therapeutics [8], autophagy is ac-
quiring a growing interest. It is a highly conserved cellular process inine seminal ribonuclease; WT,
hyladenine; FBS, fetal bovine
lcadaverine; siRNA, small inter-
r oligomers; RI, RNase inhibitor
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ights reserved.which cytoplasmic materials, including organelles, are sequestered into
double-membrane vesicles called autophagosomes and delivered to lyso-
somes for degradation or recycling. Besides its cytoprotective role in cel-
lular homeostasis, autophagy can be a form of programmed cell death,
designated as “autophagic cell death” [9]. Physiologically, autophagy has
the role to preserve the balance between organelle biogenesis, protein
synthesis and their clearance [10]. More recently, autophagy has been
shown to be an important mediator of pathological responses and to be
engaged in the cross-talkwith reactive oxygen species involved in cell sig-
naling andprotein damage [11]. Interest in the role of autophagy in cancer
research starts from the discovery that BECN1 (the gene encoding the
pro-autophagic protein Beclin1, also known as ATG6) is also a tumor sup-
pressor gene [12], revealing that autophagy is under the control of a large
panel of oncogenes and products of tumor suppressor genes [13]. The link
between autophagy and antitumor activity prompted us to investigate
the possible role of ribonucleases in this process. It is well known, in
fact, that many ribonucleases display, besides their enzymatic activity,
other remarkable biological activities [14,15], among which emerges a
relevant cytotoxic effect against tumor cells in vitro and in vivo [16,19].
These ﬁndings aroused new interest in the ﬁelds of potential anticancer
therapy related to this class of enzymes. In this work, we focused our
attention in particular on two variants belonging to the secretory
pancreatic-type RNase super-family: the proto-type bovine pancreatic ri-
bonuclease (RNase A), which is monomeric in its native state, and the
977C. Fiorini et al. / Biochimica et Biophysica Acta 1843 (2014) 976–984bovine seminal RNase (BS-RNase), a natively dimeric protein constituted
by two identical subunits covalently bound through two antiparallel di-
sulﬁde bridges. Each BS-RNase subunit shares 82% sequence identity
and very close 3D structural and dynamical features in solution with
RNase A [20]. In solution, BS-RNase is an equilibriummixture containing
70% of N-terminal-swapped [21] and 30% of unswapped isoforms, respec-
tively called MxM and M=M [22]. Notably, swapped MxM BS-RNase
evades RI because of its dimericity, which persists also under the cytosol
reducing environment [24], and can consequently bear a remarkable an-
titumor action [25], while RNase A, like most monomeric RNases, is
strongly bound and inactivated in mammalian cells by the RNase Inhibi-
tor (RI) [23]. Anyway, native RNase A can be induced [26] to form various
N- or C-terminal domain-swappeddimers [27,29], trimers [30], and larger0
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Fig. 1. Effect of RNase A and BS-RNase on growth inhibition and apoptosis in Panc1,
ﬁbroblasts, andHaCaT cells. (A and B) Cellswere seeded in 96-well plates, incubated over-
night, and treated with increasing concentrations of RNase A or BS-RNase for 72 h. Cell
proliferation was determined using the Crystal Violet colorimetric assay. Values are the
means of three independent experiments, eachperformed in triplicate. Statistical analysis:
(#) p b 0.05 Panc1 vs ﬁbroblasts or HaCaT. (C) Cells were seeded in 96-well plates, incu-
bated overnight, and treated with increasing concentrations of RNase A or BS-RNase for
72 h. Apoptosis was analyzed using the annexinV/FITC binding assay. Values are the
means (±SD) of three independent experiments, each performed in triplicate. Statistical
analysis: (*) p b 0.05.oligomers [31,32], all reconstituting the active site [26,28] and augment-
ing the enzymatic activity against dsRNAwith respect to thenativemono-
mer [33]. Despite depending on the tumor type tested [34,36], RNase A
oligomers can also acquire cytotoxic activity both in vitro and in vivo
[37]. Also BS-RNase is known to oligomerize through the 3D domain
swapping of both N- and C-termini, and its multimers show to be enzy-
matically and biologically more active than the native dimer(s) [38]. Fur-
thermore, BS-RNase activity can be increased also by mutations which
augment its basicity and capability to interact with cell membranes, as it
occurs for the G38K mutant [39] that has been tested in this work. Thus,
in the present manuscript we investigated whether the two mentioned
secretory RNases (i.e., RNase A and BS-RNase), and their respective oligo-
meric aggregates, could display an efﬁcient anti-proliferative activity
against pancreatic adenocarcinoma cells, as compared to nontumorigenic
cell lines. Furthermore, considering its relevant role in the cell life-
balance, we explored if autophagy could have a role in the RNase-
mediated cancer cell death.0
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Fig. 2. Effect of RNase A and BS-RNase on autophagy in Panc1, ﬁbroblasts, and HaCaT cells.
(A and B) Cells were seeded in 96-well plates, incubated overnight, and treated with
increasing concentrations of RNase A or BS-RNase for 72 h. Autophagosome formation
assaywas analyzed using the incorporation ofMDCprobe. Values are themeans of three in-
dependent experiments, each performed in triplicate. Statistical analysis: (#) p b 0.05 Panc1
vs ﬁbroblasts or HaCaT. (C) Cells were seeded in 60-mmdiameter culture dishes, incubated
overnight, and treated with 100 μg/ml RNase A or BS-RNase for 32 h. Whole-cell extracts
were used for Western blot analysis of the autophagy-related proteins Beclin1 and LC3.
Ponceau S staining was used as control loading. (D) Quantitative analyses of LC3-II/LC3-I
ratio. The bands were scanned as digital peaks and the areas of the peaks were calculated
in arbitrary units, as described in the “Materials andmethods” section. The value of Ponceau
S dye was used as normalizing factor. Values are the means of three independent experi-
ments (±SD). Statistical analysis: (*) p b 0.0.
978 C. Fiorini et al. / Biochimica et Biophysica Acta 1843 (2014) 976–9842. Materials and methods
2.1. Chemicals
Chloroquine diphosphate [CQ; N4-(7-chloro-4-quinolinyl)-N1,N1-
dimethyl-1,4-pentanediamine], and 3-methyladenine (3MA) were ob-
tained from Sigma (Milan, Italy). Recombinant RNase A and BS-RNase
were produced and puriﬁed from Escherichia coli as unfolded mono-
mers, extracted from inclusion bodies and then refolded as reported in
[40]. In the case of BS-RNase, and of its G38K mutant [39], Cys-31 and
32 were linked to two glutathione molecules [40]. After selectively re-
ducing the mixed disulﬁdes, the protein was dialyzed against 0.1 M
Tris/acetate, pH 8.4, followed by SEC onto a Sephadex G-75 column to
obtain dimers [41]. The protein solution was incubated at 37 °C for at
least 72 h to reach the equilibrium between the two MxM and M=M
isoforms [41]. RNase A and BS-RNase were treated with Aeromonas
proteolytica aminopeptidase (Sigma) to removeMet-1 before cytotoxic-
ity assays.2.2. RNase A or BS-RNase oligomeric products
RNase A and BS-RNase oligomers were prepared by lyophilizing 5 to
50 mg/ml protein samples dissolved in 40% acetic acid [26], and then
re-dissolving them in 0.2 M NaPi, pH 6.75 [26,33]. Puriﬁcation of the
two mentioned RNases, or separation of their oligomers, were per-
formed, respectively, through SEC using a Sephadex G-75 column (70
× 1.5 cm), in 0.1 M Tris/acetate, pH 8.4, ﬂow rate 0.4–0.5 ml/min, or
with a Superdex 75 HR 10/300 column, attached to an ÄKTA FPLC sys-
tem (GE-Healthcare), and equilibrated with NaPi 0.20 M [33] or 0.400
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Fig. 3. Effect of autophagy inhibition on the cytotoxic and apoptotic outcomes of RNase A and B
and treatedwith increasing concentrations of RNase A or BS-RNase in the absence or presence o
colorimetric assay. Values are themeans of three independent experiments each performed in t
(B and D) Cells were seeded in 96-well plates, incubated overnight, and treated with increasin
3MA for 72 h. Apoptosis was analyzed using the annexinV/FITC binding assay. Values are the m
(#) p b 0.05 BS-RNase vs BS-RNase + CQ or BS-RNase + 3MA.M [38], pH 6.75, ﬂow rate 0.08–0.10 ml/min, at room temperature. Be-
sides native BS-RNase dimer (D), its domain-swapped oligomers were
puriﬁed as N-swapped-only or NCN-swapped tetramers (TTN and TTC,
respectively) [38,42], and larger oligomers (LO) [38]. Concerning RNase
A, beyond native monomer (M), also N- or C-swapped dimers (DN, DC),
trimers (N+ C-swapped TNC; C-swapped-only, TC), tetramers (NCN-tet-
ramer, TTN, andCNC-tetramer, TTC) or amixture of larger oligomers (LO)
[32,43] were chromatographed through a Source 15S 16/10 cation-
exchange column with a 0.09–0.20 M NaPi gradient, pH 6.75 [33]. The
puriﬁed oligomers of both RNases were kept at 4 °C until use, or
concentrated against NaPi 0.010 M, pH 6.75, in Centricon Ultra-ﬁlters
(C.O. 10 kDa, Millipore), just before use. The concentration of BS-RNase
and RNase A species was spectrophotometrically measured at 278 nm
with a ε1%278 of 4.65, and at 280 nm, ε1%280 of 7.3, respectively [38].2.3. Cell culture
Panc1 and PaCa44 human pancreatic adenocarcinoma cell lines
were grown in RPMI 1640 supplemented with 2 mM glutamine (Life
Technologies, Milan, Italy), 10% FBS, and 50 μg/ml gentamicin sulfate
(BioWhittaker, Lonza, Bergamo, Italy). Normal primary ﬁbroblasts
(PromoCell, PBI, Milan, Italy) and HaCaT nontumorigenic keratinocytes
were grown in DMEM supplemented with 2 mM glutamine (Life Tech-
nologies, Milan, Italy), 10% FBS, and 50 μg/ml gentamicin sulfate. All cell
types were incubated at 37 °C with 5% CO2. In serum starvation experi-
ments, cells were plated in culturemedium containing 10% FBS. The day
after themediumwas replaced with one containing a reduced percent-
age of FBS (1%, 0.1% or 0%) in the absence or presence of the various
compounds.0
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S-RNase in Panc1 cells. (A and C) Cells were seeded in 96-well plates, incubated overnight,
f 5 μMCQor 1mM3MA for 72 h. Cell proliferationwas determined using the Crystal Violet
riplicate. Statistical analysis: (#) p b 0.05 BS-RNase vs BS-RNase+CQor BS-RNase+ 3MA.
g concentrations of RNase A or BS-RNase in the absence or presence of 5 μM CQ or 1 mM
eans of three independent experiments each performed in triplicate. Statistical analysis:
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Fig. 4. Effect of Beclin1 knock-down on autophagy and growth inhibition by BS-RNase in
Panc1 cells. (A andB)Cellswere seeded in96-well plates, incubated overnight, transfected
with Beclin1 siRNA or non-targeting (NT) siRNA, and/or treated with 200 μg/ml BS-RNase
for 72 h. Autophagosome formation assay was analyzed using the incorporation of MDC
probe, while cell proliferation was determined using the Crystal Violet colorimetric
assay. Values are the means (±SD) of three independent experiments each performed
in triplicate. Statistical analysis: (*) p b 0.05. (C) Cellswere seeded in60-mmdiameter cul-
ture dishes, incubated overnight, transfected with Beclin1 siRNA or non-targeting (NT)
siRNA, and treated with 100 μg/ml BS-RNase for 32 h. Beclin1 expression was analyzed
bywestern blot using whole-cell extracts. Ponceau S staining was used as control loading.
979C. Fiorini et al. / Biochimica et Biophysica Acta 1843 (2014) 976–9842.4. Cell proliferation assay
Cells were seeded in 96-well plates (2.5 × 103 cells/well) and, the
day after, at the times indicated in the ﬁgure legends, they were incu-
bated with RNase A or BS-RNase in the absence or presence of autoph-
agy inhibitors. The protein concentrations are expressed as μg/ml to
better compare the effects of the two RNases, and of their oligomers,
taking into account the different MWs of the native monomeric RNase
A and dimeric BS-RNase. For example, 100 μg/ml corresponds to
7.3 μM for RNase A, while to 3.65 μM for BS-RNase. At the end of the
treatments, cells were stained with Crystal Violet solution (Sigma,
Milan, Italy). The dyewas solubilized in PBS containing 1% SDS and pho-
tometrically measured (A595nm) to determine cell growth.
2.5. Apoptosis assay
Cells were seeded in 96-well plates (2.5 × 103 cells/well) and, the
day after, treated with the various RNase compounds at the indicated
concentrations for 72 h. At the end of the treatment, cells were ﬁxed
with 2% paraformaldehyde in PBS at room temperature for 30 min,
then washed twice with PBS and stained, for 10 min in the dark, at
room temperature, with annexinV/FITC (Bender MedSystem, Milan,
Italy) in binding buffer (10 mM HEPES/HCl pH 7.4, 140 mM NaCl, and
2.5 mM CaCl2). Finally, cells were washed with binding buffer solution
and ﬂuorescence was measured by using a multimode plate reader
(λexc 485 nm and λem 535 nm) (GENios Pro, Tecan, Milan, Italy). The
values were normalized on cell proliferation by Crystal Violet assay.
2.6. Autophagosome formation assay
To quantify the induction of autophagy, cells were incubated with
the ﬂuorescent probe monodansylcadaverine (MDC; Sigma, Milan,
Italy). MDC is a selective marker for acidic vesicular organelles (AVOs),
such as autophagic vacuoles, and especially autolysosomes. Brieﬂy,
cells were seeded in 96-well plates (2.5 × 103 cells/well) and treated
with the various compounds as indicated in ﬁgure legends. At the end
of the treatments, cells were incubated in culture medium with 50 μM
MDC at 37 °C for 15 min. After incubation, cells were washed with
Hanks buffer (20 mM Hepes pH 7.2, 10 mM glucose, 118 mM NaCl,
4.6 mM KCl, and 1 mM CaCl2) and ﬂuorescence was measured by
using amultimode plate reader (λexc 340 nm and λem 535 nm) (GENios
Pro, Tecan, Milan, Italy). The values were normalized on cell prolifera-
tion by Crystal Violet assay.
2.7. siRNA transfection and Beclin1 silencing
Exponentially growing cells were seeded at a density of 2.5 × 103
cells/well in 96-well plates for proliferation assays and at 2.5 × 105
cells/plate in 60 mm cell culture plates for protein extraction. Twenty-
four hours later, transfections were carried out with a speciﬁc small
interfering (si) RNA duplex targeting Beclin1 mRNA (5′-ACAGUGAA
UUUAAACGACAGCAGCU-3′ and 5′-AGCUGCUGUCGUUUAAAUUCAC
UGU-3′) and a non-targeting (NT) siRNA (5′-CAGUCGCGUUUGCGAC
UGG-3′) purchased by Life Technologies (Monza MB, Italy). Cells were
transfected with siRNAs at a ﬁnal concentration of 50 nMusing Lipofec-
tamine 2000 (Life Technologies) for 24 h. At the end of the transfection
time, cell medium was changed and cells were treated with BS-RNase
under the conditions indicated in Fig. 4.
2.8. Immunoblot analysis
Cells were harvested, washed in phosphate-buffered saline, and re-
suspended in RIPA Buffer (50 mM Tris–HCl pH 8.0, 150 mM NaCl, 1%
Igepal CA-630, 0.5% Na-Doc, 0.1% SDS, 1 mM Na3VO4, 1 mM NaF,
2.5 mM EDTA, 1 mM PMSF, and 1× protease inhibitor cocktail). After
three freeze/thaw cycles and incubation on ice for 30 min, lysate wascentrifuged at 14,000 ×g for 10 min at 4 °C and the supernatant used
for Western blot. Protein concentration was measured with the
Bradford protein assay reagent (Pierce, Milan, Italy) using bovine
serum albumin as a standard. Protein extracts (50 μg/lane) were
electrophoresed through a 12% SDS-polyacrylamide gel and electro-
blotted onto PVDF membranes (Millipore, Milan, Italy). Membranes
were incubated in blocking solution [5% BSA in TBST (50 mM Tris pH
7.5, 0.9% NaCl, 0.1% Tween 20)] for 1 h at room temperature and probed
overnight at 4 °C with a rabbit monoclonal anti-LC3 (1:1000) (Cell
Signaling) or a rabbit polyclonal anti-Beclin1 (1:1000) (GeneTex, cat.
n° GTX113039). Horseradish peroxidase conjugated anti-rabbit IgGs
(1:8000 in blocking solution) (Upstate Biotechnology, Milan, Italy)
were used to detect speciﬁc proteins. Immunodetection was carried
out using chemiluminescent substrates (Amersham Pharmacia Biotech,
Milan, Italy) and recorded using a HyperﬁlmECL (Amersham Pharmacia
980 C. Fiorini et al. / Biochimica et Biophysica Acta 1843 (2014) 976–984Biotech). The bands were scanned as digital peaks, and the areas of the
peaks were calculated in arbitrary units using the public domain NIH
Image software (http://rsb.info.nih.gov/nih-image/). The value of
Ponceau S dye was used as a normalizing factor.2.9. Statistical analysis
ANOVA analysis was performed by GraphPad Prism 5 software.
p value b0.05 was indicated as being statistically signiﬁcant.3. Results
3.1. BS-RNase, but not RNase A, inhibits pancreatic adenocarcinoma cell
growth and stimulates apoptosis
To analyze the effect of the pancreatic-type secretory ribonucleases
RNase A and BS-RNase on pancreatic adenocarcinoma cell growth, we
used Panc1 cell line whichwe previously demonstrated to be highly re-
sistant to chemotherapy as a cellular model [44]. Panc1 cancer cells
were resistant to RNase A treatment (Fig. 1A), while theywere sensitive
to BS-RNase, with a ~60% cell growth inhibition after treatment with
200 μg/ml of enzyme (Fig. 1B). Similar data have been observed also
with another pancreatic adenocarcinoma cell line, PaCa44, establishing
that these events were not restricted to the speciﬁc cancer cell line cho-
sen (Supplemental Fig. 1A). Intriguingly, normal primary ﬁbroblasts and
HaCaT nontumorigenic keratinocytes were signiﬁcantly less affected by
BS-RNase than Panc1 cancer cells (Fig. 1B). Accordingly with cell prolif-
eration results, BS-RNase, but not RNase A, strongly induced apoptosis
in Panc1 cancer cells, while non-tumoral cells were signiﬁcantly less
affected (Fig. 1C).0
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Fig. 5. Effect of autophagy inhibition on the cytotoxic and apoptotic outcomes of RNase A and B
were seeded in 96-well plates, incubated overnight, and treated with increasing concentrations
blasts and HaCaT cells, respectively, were seeded in 96-well plates, incubated overnight, and tre
1 mM 3MA for 72 h. Cell proliferation was determined using the Crystal Violet colorimetric ass3.2. BS-RNase, contrarily to RNase A, induces Beclin1-mediated autophagic
cell death in cancer cells
To further characterize the biological events regulated by the two
mentioned RNases in pancreatic adenocarcinoma cells, we investigated
whether autophagy could be a mechanism involved in cell proliferation
inhibition. Fig. 2A clearly shows that RNase A did not signiﬁcantly affect
autophagosome formation, while in cancer cells this event was strongly
stimulated by BS-RNase in a concentration-dependent manner (Fig. 2B).
Similar results have been obtained in pancreatic adenocarcinomaPaCa44
cell line (Supplemental Fig. 1B). Conversely, BS-RNase was able to
induce autophagy only slightly either in normal ﬁbroblasts or in HaCaT
keratinocytes. To conﬁrm and further characterize the autophagy in-
duced by BS-RNase in cancer cells, we performedWestern blot analyses
of the autophagy-related proteins Beclin1 and LC3. Accordinglywith pre-
vious data, RNase A did not affect expression of both Beclin1 and LC3 iso-
forms (Fig. 2C). Conversely, BS-RNase strongly induced the expression of
both Beclin1 and LC3-II, the phosphoethanolaminated and functionally
active form of the autophagosome protein LC3-I. Since the conversion
of LC3-I in LC3-II is required for autophagosome formation, we analyzed
the LC3-II/LC3-I ratio after treatment with ribonucleases, revealing
that BS-RNase strongly increased this ratio (~4-fold) in cancer cells
(Fig. 2D). This result reveals the formation of the intracellular
autophagosomes, which, after fusion with lysosomes, constitute acidic
vesicular organelles (AVOs) detectable by monodansylcadaverine stain-
ing (see Fig. 2B). Since autophagy has been described as a double-edged
sword event, i.e., a protective mechanism of cells in response to stress
stimuli or, conversely, a mortal mechanism, named autophagic cell
death [9,10], we analyzed the impact of autophagy stimulation on
Panc1 cell growth inhibition and apoptosis induced by ribonucleases.
To do so, we used the autophagy inhibitors chloroquine (CQ) or 3-
methyladenine (3MA). No alteration on cell growth and apoptosis was0
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Fig. 6. Effect of serum starvation on growth inhibition and autophagy by BS-RNase in
Panc1 cells. (A) Cells were seeded in 96-well plates, incubated overnight, and treated with
200 μg/ml BS-RNase in culture media containing percentages of FBS ranging from 10% to
0%, in the absence or presence of 5 μM CQ or 1 mM 3MA for 72 h. Cell proliferation was de-
termined using the Crystal Violet colorimetric assay. Values are the means (±SD) of three
independent experiments each performed in triplicate. Statistical analysis: (*) p b 0.05.
(B) Cells were seeded in 96-well plates, incubated overnight, and treated with 200 μg/ml
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72 h. Autophagosome formation assay was analyzed using the incorporation of MDC
probe. Values are the means (±SD) of three independent experiments each performed in
triplicate. Statistical analysis: (*) p b 0.05.
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of the autophagy inhibitors CQor 3MA(Fig. 3A andB). Conversely, Fig. 3C
shows that BS-RNase-mediated cancer cell growth inhibition was
strongly reduced in the presence of CQ or 3MA, whichwere instead inef-
fective when used alone (Supplemental Fig. 2A). Consistently, Fig. 3D re-
ports that apoptosis induced by BS-RNase was signiﬁcantly attenuated
by autophagy inhibitors. The efﬁciency of CQ and 3MA in the autophagy
inhibition event was checked by their relative inhibitory effect on the
autophagosome formation stimulated by BS-RNase treatment (Supple-
mental Fig. 2B). Altogether, these data indicate a key role played by
autophagy on the cytotoxic effect of BS-RNase in pancreatic cancer cells.
To further characterize the mechanism of autophagy induction trig-
gered by BS-RNase, we performed knock-down experiments of Beclin1
by siRNA transfection, showing that Beclin1 siRNA signiﬁcantly rescued
autophagy induced by BS-RNase alone or by BS-RNase in the presence
of non-targeting siRNA as negative control (Fig. 4A). Accordingly with
the cell death feature of autophagy shown in Fig. 3C and D, Beclin1
knock-down determined a signiﬁcant reduction of the cytotoxic effect
of BS-RNase (Fig. 4B). Western blot analysis was used to check Beclin1
silencing after siRNA transfection (Fig. 4C). Since BS-RNase was able to
stimulate low levels of autophagosome formation in normal ﬁbroblasts
and HaCaT cells, we investigated whether this event could have a role
on cell growth inhibition by BS-RNase in these non-tumoral cells.
ConcerningRNaseA,whichwasnot able to stimulate autophagy, the ad-
dition of the autophagy inhibitors CQ or 3MA to RNase A treatment did
not determine any alteration on ﬁbroblast and HaCaT cell growth
(Fig. 5A and B). Interestingly, autophagy inhibitors failed to modify
also BS-RNase-mediated growth inhibition in these normal cell types
(Fig. 5C and D), suggesting that autophagy stimulated by BS-RNase
may be considered a cancer-related cell death mechanism. To analyze
the role of cancer cell proliferation rate in response to BS-RNase, we an-
alyzed Panc1 cell growth and autophagy affected by BS-RNase in serum
starvation, a well described condition favoring a quiescent state of the
cells [45]. The decrease of serumpercentage in culturemedium strongly
reduced the cytotoxic activity of BS-RNase in Panc1 cancer cells, as com-
pared to their relative untreated cells (Fig. 6A). Furthermore, the rescue
of cell growth inhibition by autophagy inhibitors CQ or 3MA progres-
sively disappeared under serum starvation conditions and, accordingly,
autophagy induced by BS-RNase treatment gradually decreased
(Fig. 6B). Altogether, these data strongly suggest that the intrinsic
higher proliferation rate of cancer cells with respect to normal cells
may play a crucial role in their preferential vulnerability to BS-RNase
treatment.
3.3. G38K BS-RNasemutant or BS-RNase oligomerization represent efﬁcient
strategies to enhance autophagic cell death in cancer cells
To analyze different strategies addressed to enhance the response of
cancer cells to BS-RNase, we ﬁrst compared the cytotoxic and autopha-
gic outcome induced by WT or G38K BS-RNases in Panc1 cancer cells
and normal ﬁbroblasts. Although the G38Kmutant determined a signif-
icant increase of the cytotoxic effect in both Panc1 cells and ﬁbroblasts
as compared to WT BS-RNase, the amount of the antiproliferative po-
tentiation in Panc1 cancer cells was higher than that obtained in normal
cells (Fig. 7A and B), further amplifying the differential response be-
tween cancer and normal cells to BS-RNase treatment. Intriguingly,
G38K mutant very strongly enhanced also the autophagic response of
cancer cells as compared to that obtained with WT BS-RNase, without
improving the autophagic outcome in normal ﬁbroblasts (Fig. 7C).
In addition, since it is well known that oligomerization of ribonucle-
ases enhances their enzymatic activity [33,38,46] we investigatedwheth-
er both RNase A or BS-RNase domain-swapped oligomers could further
stimulate autophagic cell death in Panc1 cancer cells. Fig. 8A and B
show that, besides native RNase A monomer, its dimers (DN and DC),
trimers (TNC, TC), tetramers (TTN and TTC) [33] or larger oligomers (LO)
[31] were not able to signiﬁcantly induce autophagy and cell growthinhibition in Panc1 cells. Conversely, BS-RNase tetramers (TTN and TTC)
[38] or larger oligomers (LO) [38] signiﬁcantly potentiated both autopha-
gy and inhibition of cancer cell growth with respect to the native dimer
(D) [38]. Interestingly, this phenomenon is well correlated with the
dimension of BS-RNase multimers (D b TTN ≈ TTC b LO), suggesting
their potential use to enhance the autophagic response of cancer cells to
BS-RNase treatment.
4. Discussion
At its endogenous basal rate, autophagy exercises quality control of
the cytoplasm of most cells by removing damaged organelles and pro-
tein aggregates [47,48]. Advances in understanding of the autophagic
process paved theway for the discovery of the importance of autophagy
in many physiological events, such as development, tissue homeostasis,
metabolism, immune response and various diseases, including cancer
[47,49]. However, the role of autophagy in tumors is complex and
ranges from being a tumor suppressor role to exerting an action in cell
982 C. Fiorini et al. / Biochimica et Biophysica Acta 1843 (2014) 976–984survival and environment adaptation [50,51]. Accordingly with this
dual-role of autophagy, our research group recently demonstrated
that pancreatic adenocarcinoma cell lines can react to various stimuli in-
ducing a cyto-protective [52] or a cell death-related autophagic re-
sponse [11,53,54]. Nonetheless, deeper efforts are needed to identify
themechanisms lying at the basis of this differential response of cancers
cells.
The present work represents the ﬁrst strong evidence of a key role
for autophagy played by the biological activity mediated by the secreto-
ry protein BS-RNase. Accordingly with our data, two very recent studies
revealed that RNase L, a nearly ubiquitous enzyme present in mamma-
lian cells that lies dormant until viral infections occur, triggers autopha-
gy in response to the infections and affects the viral pathogenesis
outcomes [55,56].
Here, we demonstrate for the ﬁrst time that autophagy is induced in
cancer cells by BS-RNase, but not by RNase A, and that this ﬁnding
encloses a cancer cell death feature. Indeed, the addition of the autoph-
agy inhibitors, CQ or 3MA, strongly reduced both pancreatic adenocarci-
noma cytotoxicity and apoptotic cell death, suggesting that autophagy
could represent a preparatory mechanism of apoptosis induced by
BS-RNase treatment. Autophagy stimulation by BS-RNase is further
recognized by the conversion of the autophagosome protein LC3-I in
its phosphoethanolaminated form LC3-II, which is involved in the elon-
gation of the autophagosomal membrane. LC3-II is often used as a
marker of autophagy and accompanied by the induction of Beclin1,
one of the main regulators of autophagosome formation. Beclin1 is a
pro-autophagic protein that has been extensively studied as a tumor-
suppressor factor and as an interactor of the anti-apoptotic Bcl-2 family
members (Bcl-2/Bcl-XL) [57]. However, many studies have uncovered a
number of Beclin1-dependent and -independent autophagy pathways,
indicating that autophagy is a very complex process [58]. Our results
of RNA silencing clearly demonstrate that Beclin1 plays a role in the au-
tophagy induced by BS-RNase. Nonetheless, since Beclin1 silencing
failed to completely abolish autophagy by BS-RNase, other Beclin1-
independent pathways could exist, such as MAPK (ERK, JNK, or p38)0
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Comparing the effect of the two pancreatic-type RNases tested
(RNase A and BS-RNase) on pancreatic adenocarcinoma cells, we clearly
revealed that, despite both enzymes displaying an appropriate enzy-
matic activity [33,59], cancer cells were unequivocally resistant to na-
tive RNase A, while they were highly sensitive to BS-RNase natural
dimer. These data can be mainly explained by the inhibitory effect of
the RNase inhibitor (RI), described to strongly bind most monomeric
pancreatic-like RNases, including RNase A, in mammalian cells [23].
Conversely, BS-RNase, although sharing about 82% of sequence identity
with RNase A and a closely conserved 3D structure of its subunit(s) [20],
has the appropriate structural determinants which allow the protein to
keep a dimeric structure able to evade RI interaction even under the re-
ducing cytosolic environment [60]. This unique feature, together with
its pI (10.3), higher than the one of RNase A (9.3), allows BS-RNase to
bear a strong antitumor action [25,29,39].
Remarkably, we show that BS-RNase induced a quite low and
ineffective level of autophagy stimulation in normal ﬁbroblasts and
nontumorigenic HaCaT cells, as compared to cancer cells. Indeed, au-
tophagy inhibitors did not signiﬁcantlymodify cell growth of ﬁbroblasts
and HaCaT cells, suggesting autophagy to be a cancer-related mecha-
nism of cell death induced by BS-RNase. To unravel this ﬁnding we
investigatedwhether the high proliferation rate, a typical feature of can-
cer cells, may play a critical role in the stronger response to BS-RNase
treatment of cancer than normal cells. Since serum starvation is a classic
condition determining cell cycle arrest and quiescence [45], we ana-
lyzed autophagic cell death in Panc1 cells under gradual serum starva-
tion demonstrating that this condition is able to completely abolish
autophagy stimulation by BS-RNase strongly reducing its cytotoxic
effect.
In addition, we tested different approaches to enhance autophagic
cell death in cancer cells by BS-RNase-related treatments. We reveal
here that the G38Kmutant BS-RNase, with an enhanced positive charge
as compared with WT, determined a deﬁnitely higher autophagic cellfibroblasts
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explained by the higher capability of G38K mutant to interact with the
very acidic membrane lipids of cancer cells with respect to WT [39].
This effect is in line with the stronger interaction of G38K mutant with
anionic phospholipid bilayers observed by SPR measurements and
with its deeper insertion in liposomes that we previously reported
[39]. In addition, we cannot exclude that the increased cluster of
positive charges on protein surface can also enhance the capability of
BS-RNase to evade RI binding, producing a 3–4 fold increase in autoph-
agic cell death induced by G38K mutant.
Furthermore, since we previously demonstrated that various artiﬁ-
cial N- or C-terminal domain-swapped oligomers of both RNase A and
BS-RNase displayed an increased enzymatic activity against dsRNA, as
compared to the native enzymes [33,38], we investigated here whether
this feature could determine a potentiated autophagic cell death in cancer
cells. Intriguingly, we demonstrate that RNase A oligomers failed to stim-
ulate autophagy and cell growth inhibition, while BS-RNase multimers
strongly enhanced autophagic cell death in pancreatic cancer cells, with
an activity increasing with the oligomers' size (D b TTN ≈ TTC b LO).
Indeed, multimerization increases both catalytic and biological activities
of RNases by enhancing substrate afﬁnity and cell membrane interaction
because of the augmented basic charge density of the oligomers
[19,33,37,38]. Despite sensitivity of cells to RNase A oligomers may de-
pend on many factors [19,34,35,61], the differential effect shown by theoligomerization of the two RNases could be ascribable mainly to the fol-
lowing reasons: i) a lower basic net charge, or charge exposure, of
RNase A with respect to BS-RNase [29,39]; ii) the relative higher stability
in solution of domain-swapped BS-RNase oligomers with respect to
RNase A ones. Anyway, a partial reconversion of RNase A or BS-RNase
oligomers to their native species can lead to a monomer blocked by RI
or to an active swapped dimer which can evade RI interaction,
respectively.
5. Conclusions
Our data indicate that BS-RNase, but not RNase A, strongly
inhibits pancreatic adenocarcinoma cell proliferation triggering Beclin1-
mediated autophagic cell death. The potential use of the more active
G38Kmutant or BS-RNase oligomersmay be considered as a novel prom-
ising therapeutic tool against pancreatic adenocarcinoma. This study pro-
vides the rational basis for future investigationswhich could be addressed
to evaluate the anti-tumoral in vivo efﬁciency of nanovectors containing
active RNases, as BS-RNase is.
Supplementary data to this article can be found online at http://dx.
doi.org/10.1016/j.bbamcr.2014.01.025.
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